SCHEMBL3846535

SCHEMBL3846535

CSc1ccc(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(C)cc4)cc23)s1

nearest known ligand 0.32

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
CD38 P28907 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 2/20 0.31
TSHR P16473 2/20 0.31
CYP2C19 P33261 2/20 0.31
CLK4 Q9HAZ1 2/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP2C9 P11712 1/20 0.31
MAPK1 P28482 1/20 0.31
TGFBR1 P36897 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852824 0.92 KDM4E (0.33) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL4716874 0.92 CYP3A4 (0.33) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3851042 0.91 CYP1A2 (0.35) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3855612 0.91 MAP4K4 (0.34) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3845563 0.90 EGFR (0.33) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3856406 0.90 AURKA (0.35) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3846715 0.89 F2RL3 (0.33) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3852013 0.89 CYP2D6 (0.35) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3846175 0.88 TGFBR1 (0.31) CD38TGFBR1
SCHEMBL3848783 0.88 PIK3CD (0.42) PIK3CDPIK3CAPIK3CBMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed